A real-world analysis of patient-reported outcomes in patients with migraine by preventive treatment eligibility status in the US and Europe.

Ford, Janet H; Foster, Shonda A; Nichols, Russell M; Tockhorn-Heidenreich, Antje; Ye, Wenyu; Jackson, James; Cotton, Sarah

Ford, Janet H; Foster, Shonda A; Nichols, Russell M; Tockhorn-Heidenreich, Antje; Ye, Wenyu; Jackson, James; Cotton, Sarah.

Afiliación

Ford JH; Eli Lilly and Company, 893 S. Delaware Street, Indianapolis, IN, 46225, USA. ford_janet@lilly.com.
Foster SA; Eli Lilly and Company, 893 S. Delaware Street, Indianapolis, IN, 46225, USA.
Nichols RM; Eli Lilly and Company, 893 S. Delaware Street, Indianapolis, IN, 46225, USA.
Tockhorn-Heidenreich A; Eli Lilly and Company, Erl Wood Manor, UK.
Ye W; Eli Lilly and Company, 893 S. Delaware Street, Indianapolis, IN, 46225, USA.
Jackson J; Adelphi Real World, Bollington, UK.
Cotton S; Adelphi Real World, Bollington, UK.

J Patient Rep Outcomes ; 4(1): 53, 2020 Jul 06.

Article en En | MEDLINE | ID: mdl-32632891

Palabras clave

Burden of disease; Migraine; Patient-reported outcomes; Preventive eligibility

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Patient Rep Outcomes Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google